Please see Full Prescribing Information below for LATISSE® (bimatoprost ophthalmic solution) 0.03% below.
Please visit http://www.allergan.com/assets/pdf/latisse_pi.pdf for Full Prescribing Information.
This is the TV commercial for LATISSE®, the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes. Visit http://www.latisse.com to learn more.
LATISSE® solution is a prescription treatment for hypotrichosis (inadequate or not enough lashes) to grow eyelashes longer, fuller and darker.
IMPORTANT SAFETY INFORMATION
If you are using, or have used, prescription products for any eye pressure problems, only use LATISSE® under close doctor care. LATISSE® use may cause increased brown pigmentation of the colored part of the eye which is likely permanent. Eyelid skin darkening may occur which may be reversible. ONLY APPLY AT THE BASE OF THE UPPER EYELASHES. DO NOT APPLY to the lower eyelid. Hair growth may occur in other skin areas that LATISSE® solution frequently touches. If you experience any eye problems or have eye surgery, consult your doctor immediately about continued use of LATISSE®. The most common side effects after using LATISSE® solution are itchy eyes and/or eye redness. If discontinued, lashes will gradually return to their previous appearance.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.
ALLERGAN © 2011 Allergan, Inc. Irvine, CA 92612. ® marks owned by Allergan, Inc.
APC70RP11
Loading...
Link to this comment:
All Comments (0)